XWEL on Nasdaq

Vringo

Logo: Vringodood, CC BY-SA 3.0, via Wikimedia Commons4

Technology company

Vringo was a technology company that became involved in the worldwide patent wars. The company won a 2012 intellectual property lawsuit against Google, in which a U.S. District Court ordered Google to pay 1.36 percent of U.S. AdWords sales. Analysts estimated Vringo's judgment against Google to be worth over $1 billion.3 Its shares trade on Nasdaq under the symbol XWEL.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

2006Founded1

Compare with Dolphin Entertainment, Regis Corporation or CARRIAGE SERVICES INC, or pick any stock.

  • TickerXWEL on Nasdaq1
  • Industryconsumer electronics industry1
  • HeadquartersNew York City1
  • Websitevringoip.com/cgi-bin/index.pl
  • Incorporated inDE5
  • Business address254 West 31St Street, 11Th Floor, New York, Ny 100015
  • Filer categoryNon-accelerated filer, Smaller reporting company5
  • Legal formCorporation

Vringo was a technology company that became involved in the worldwide patent wars. The company won a 2012 intellectual property lawsuit against Google, in which a U.S. District Court ordered Google to pay 1.36 percent of U.S. AdWords sales. Analysts estimated Vringo's judgment against Google to be worth over $1 billion. The Court of Appeals for the Federal Circuit overturned the District Court's ruling on appeal in August 2014 in a split 2-1 decision, which Intellectual Asset Magazine called "the most troubling case of 2014." Vringo appealed to the United States Supreme Court. Vringo also pursued worldwide litigation against ZTE Corporation in twelve countries, including the United Kingdom, Germany, Australia, Malaysia, India, Spain, Netherlands (the Hague), Romania, China, Malaysia, Brazil and the United States. The high profile nature of the intellectual property suits filed by the firm against large corporations known for anti-patent tendencies has led some commentators to refer to the firm as a patent vulture or patent troll.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

25.7%Gross margin7
-53.6%Operating margin7
-58.2%Net margin7
-13.8%Revenue growth, 20257
-$11.7MFree cash flow7

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Service brought in 90% of the revenue Vringo broke down this way in fiscal 2025.

  1. Service$26.3M790%down 14% from 2024
  2. Product$2.9M710%down 9% from 2024
Products and services by year
Products and services20242025
Service$30.7M$26.3M
Product$3.2M$2.9M

Business segments

Xpres Spa brought in 64% of the revenue Vringo broke down this way in fiscal 2025.

  1. Xpres Spa$18.6M764%down 1% from 2024
  2. Xpres Test$8.2M728%down 37% from 2024
  3. Naples Wax$2.3M78%up 11% from 2024
Business segments by year
Business segments20242025
Xpres Spa$18.8M$18.6M
Xpres Test$13.1M$8.2M
Naples Wax$2.1M$2.3M

Regions

United States brought in 80% of the revenue Vringo broke down this way in fiscal 2025.

  1. United States$23.4M780%down 16% from 2024
  2. Outside the United States$5.8M720%down 5% from 2024
Regions by year
Regions20242025
United States$27.8M$23.4M
Outside the United States$6.1M$5.8M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue58¢$21.7M
  • Selling, general and admin42¢$16.0M
  • Income tax0¢$29.0K

Out of $29.2M in revenue.7 The company lost money this year.

Financial statements

Revenue891011127$29.2M in 2025−40% since 2019
0$20.0M$40.0M$60.0M$80.0M2019: $48.5M$48.5M20192020: $8.4M$8.4M2020−83%2021: $73.7M$73.7M2021+779%2022: $55.9M$55.9M2022−24%2023: $30.1M$30.1M2023−46%2024: $33.9M$33.9M2024+13%2025: $29.2M$29.2M2025−14%
Gross profit1011127$7.5M in 2025−77% since 2021
0$10.0M$20.0M$30.0M$40.0M2021: $32.3M$32.3M20212022: $12.0M$12.0M2022−63%2023: $3.7M$3.7M2023−69%2024: $8.9M$8.9M2024+142%2025: $7.5M$7.5M2025−16%
Operating income891011127-$15.7M in 2025−1% since 2019
-$60.0M-$40.0M-$20.0M0$20.0M2019: -$15.9M-$15.9M20192020: -$40.1M-$40.1M2020+153%2021: $4.1M$4.1M20212022: -$31.2M-$31.2M20222023: -$28.2M-$28.2M2023−9%2024: -$16.7M-$16.7M2024−41%2025: -$15.7M-$15.7M2025−6%
Net income891011127-$17.0M in 2025−20% since 2019
-$100.0M-$75.0M-$50.0M-$25.0M0$25.0M2019: -$21.2M-$21.2M20192020: -$90.5M-$90.5M2020+326%2021: $3.3M$3.3M20212022: -$32.8M-$32.8M20222023: -$27.7M-$27.7M2023−16%2024: -$16.9M-$16.9M2024−39%2025: -$17.0M-$17.0M2025+1%
Fiscal year2019202020212022202320242025
Revenue$48.5M8$8.4M9$73.7M10$55.9M11$30.1M12$33.9M7$29.2M7
Cost of revenue$37.9M8$12.0M9$41.4M10$43.9M11$26.4M12$25.0M7$21.7M7
Gross profit$32.3M10$12.0M11$3.7M12$8.9M7$7.5M7
Research and development
Selling, general and admin$14.3M8$15.9M9$24.2M10$21.2M11$13.0M12$20.1M7$16.0M7
Operating expenses$28.2M10$43.2M11$31.9M12$25.6M7$23.2M7
Operating income-$15.9M8-$40.1M9$4.1M10-$31.2M11-$28.2M12-$16.7M7-$15.7M7
Interest$2.9M15
Income before tax$2.9M10-$32.6M11-$28.0M12-$16.4M7-$16.1M7
Income tax-$146.0K8$7.0K9$56.0K10$55.0K11$35.0K12$49.0K7$29.0K7
Net income-$21.2M8-$90.5M9$3.3M10-$32.8M11-$27.7M12-$16.9M7-$17.0M7
Earnings per share-$2.059$0.0310-$7.0111-$6.6412-$3.667-$5.087
Earnings per share (diluted)-$2.059$0.0310-$7.0111-$6.6412-$3.667-$5.087
Shares (weighted, basic)104.3M shares104.7M shares114.2M shares124.6M shares75.6M shares7
Shares (weighted, diluted)105.1M shares104.7M shares114.2M shares124.6M shares75.6M shares7

Compare Vringo with another company

Corporate structure

Vringo sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Vringo

  • Vringo New York City

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Vringo reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$7.6M7 Dec 31, 2025$5.6M7 Dec 31, 2024+34.4%
Accumulated depreciation$5.9M7 Dec 31, 2025$3.8M7 Dec 31, 2024+54.4%
Property and equipment, net$1.7M7 Dec 31, 2025$1.8M7 Dec 31, 2024−8.0%
Operating-lease assets (leased space)$1.0M7 Dec 31, 2025$3.4M7 Dec 31, 2024−69.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$2.6M7 Dec 31, 2025$4.5M7 Dec 31, 2024−42.5%
Marketable securities, current$7.0K7 Dec 31, 2025$7.2M7 Dec 31, 2024−99.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$1.4M7 Dec 31, 2024$1.4M12 Dec 31, 2023+1.3%
Intangible assets, net (excluding goodwill)$101.0K7 Dec 31, 2025$1.0M7 Dec 31, 2024−90.1%
Finite-lived intangibles, gross$3.8M7 Dec 31, 2025$3.8M7 Dec 31, 20240%
Accumulated amortization$3.7M7 Dec 31, 2025$2.8M7 Dec 31, 2024+33.3%
Finite-lived intangibles, net$101.0K7 Dec 31, 2025$1.0M7 Dec 31, 2024−90.1%

Inventory

ItemLatestA year beforeChange
Inventory, total$509.0K7 Dec 31, 2025$501.0K7 Dec 31, 2024+1.6%

Properties, in its own words

As of December 31, 2025, besides our Global Support Center at 254 West 31st Street in New York City, XWELL had 35 spas and wellness centers in 31 airport and off-airport locations, in the United States, Netherlands, Turkey, and the United Arab Emirates. All of the locations as of that date were leased, typically with one or two renewal options after the initial term. Economic terms vary by type and location of store, and on average, the lease terms are 5-10 years with several locations operating on a month-to-month basis. We believe that our facility and our leases are adequate to accommodate our business needs.

Item 2 of the 10-K filed Apr 1, 2026.16

The story

Vringo was founded in 2006 by Israeli entrepreneurs and venture capitalist Jonathan Medved and mobile software specialist David Goldfarb. The company was initially funded by private equity firm Warburg Pincus in 2007. By December 2009, it had raised $14 million in funding. Vringo priced its initial public offering on June 22, 2010, and raised $11 million.

On March 14, 2012, Vringo entered into a definitive agreement to merge with Innovate/Protect, an intellectual property company founded by Andrew Kennedy Lang, the former chief technology officer at Lycos, and Alexander R. Berger, a Vice President at Hudson Bay Capital Management. At that time, Andrew Perlman, Vringo's then-President, replaced Jonathan Medved as CEO. The merger with Innovate/Protect was completed on July 19, 2012, with Lang joining Vringo as chief technology officer, and Berger as chief operating officer. Innovate/Protect directors H. Van Sinclair, Chief Executive Officer of the RLJ Companies, and Donald E. Stout, the president of NTP, Inc., which collected $612.5 million from BlackBerry-maker RIM, joined the Vringo board of directors in connection with the merger.

James Altucher, a graduate school colleague of Lang, posted an article on Tech Crunch drawing attention to the history of the patents that Vringo had acquired from Lycos. On April 13, 2012, billionaire investor Mark Cuban, the owner of the Dallas Mavericks and "shark" investor on the television series Shark Tank, disclosed a 7.4% stake in the company.

The company was invited to ring the opening bell at the New York Stock Exchange on August 1, 2012, to mark the successful completion of the merger. In August 2012, the company raised $31.2 million to buy 124 patent families relating to telecommunications and infrastructure technology from Nokia Corp. In an October 2012 common stock offering, Vringo raised an additional $45 million. In April 2013, Vringo's shares commenced trading on the NASDAQ.

From Wikipedia’s article on Vringo, shared under CC BY-SA 4.0.6

Leadership

Who has led Vringo, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (29)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Chief Financial OfficerThomas Ian Brown named Jan 28, 2025 to Mar 3, 202657
  • Chairman of the BoardBruce Ian Bernstein named Jan 28, 2025 to Mar 3, 202657
  • DirectorRobert Ian Weinstein named Jan 28, 2025 to Mar 3, 202657

Former names

  • XpresSpa Group, Inc.Jan 5, 2018 to Oct 7, 20225
  • FORM Holdings Corp.May 23, 2016 to Dec 29, 20175
  • Vringo IncAug 20, 2007 to May 5, 20165

Timeline

  1. Oct 8, 20268-K Entered a material agreement58
  2. Aug 5, 20268-K Executive or director change; Regulation FD disclosure59
  3. Jul 9, 20268-K Entered a material agreement; Regulation FD disclosure60
  4. Apr 10, 20268-K Shareholder vote61
  5. Apr 1, 20268-K Results of operations62
  6. Mar 4, 20268-K Entered a material agreement; Unregistered sale of shares; Change to shareholders' rights63
  7. Feb 25, 20268-K Entered a material agreement; Unregistered sale of shares; Executive or director change64
  8. Dec 18, 20258-K Shareholder vote65
  9. Dec 5, 20258-K Listing notice or transfer66
  10. Nov 14, 20258-K Change to shareholders' rights; Bylaws or fiscal year changed67
  11. Nov 14, 20258-K Results of operations68
  12. Nov 7, 20258-K Director nominations69
  13. Jan 9, 2023New chief executive Ezra Ernst becomes CEO17
  14. Apr 22, 2022New chief executive Scott R. Milford becomes CEO18
  15. Feb 13, 2019New chief executive Doug Satzman becomes CEO19
  16. Jun 22, 2010New chief executive Jonathan Medved becomes CEO20
  17. 2006Founded Founded1

Calendar

Coming up

  1. Nov 13, 2026Reports results for the quarter ending Sep/202670

When it reported results

  1. Apr 1, 2026Reported quarterly or annual results62
  2. Nov 14, 2025Reported quarterly or annual results68
  3. Aug 14, 2025Reported quarterly or annual results71
  4. May 20, 2025Reported quarterly or annual results72
  5. Apr 15, 2025Reported quarterly or annual results73
  6. Nov 14, 2024Reported quarterly or annual results74
  7. Aug 14, 2024Reported quarterly or annual results75
  8. May 15, 2024Reported quarterly or annual results76

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

257 filings to the SEC since October 2021: 11 annual reports, 15 quarterly reports, 74 major events, 74 insider forms, 14 large holders, 2 private raises, 67 other. The latest 20:

  1. Oct 8, 2026DEF 14A EDGAR
  2. Oct 8, 20268-K EDGAR
  3. Sep 8, 2026SCHEDULE 13D/A EDGAR
  4. Sep 4, 20264 OWNERSHIP DOCUMENT EDGAR
  5. Sep 4, 20263 OWNERSHIP DOCUMENT EDGAR
  6. Sep 3, 20264 OWNERSHIP DOCUMENT EDGAR
  7. Sep 2, 20264 OWNERSHIP DOCUMENT EDGAR
  8. Sep 2, 20264 OWNERSHIP DOCUMENT EDGAR
  9. Sep 2, 20264 OWNERSHIP DOCUMENT EDGAR
  10. Aug 14, 202610-Q EDGAR
  11. Aug 13, 2026SCHEDULE 13G/A EDGAR
  12. Aug 12, 2026SCHEDULE 13G/A EDGAR
  13. Aug 5, 20268-K EDGAR
  14. Aug 4, 2026SCHEDULE 13D EDGAR
  15. Jul 27, 2026PREM14A EDGAR
  16. Jul 9, 20268-K EDGAR
  17. Jun 11, 2026SCHEDULE 13G EDGAR
  18. May 20, 202610-Q EDGAR
  19. May 15, 2026NT 10-Q EDGAR
  20. Apr 30, 202610-K/A EDGAR

The 257 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

24 open-market trades by officers, directors and large owners since October 2021: 14 buys and 10 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 11, 2024Wizenberg Gaelle SandraDirectorBuy1,201$1.65$2.0KForm 4
May 7, 2024Wizenberg Gaelle SandraDirectorBuy199$1.85$368Form 4
Apr 26, 2024Wizenberg Gaelle SandraDirectorBuy100$1.83$183Form 4
May 30, 2023WEINSTEIN ROBERTDirectorBuy25,000$0.25$6.2KForm 4
May 26, 2023WEINSTEIN ROBERTDirectorBuy25,000$0.25$6.2KForm 4
Dec 6, 2022Milford Scott RPresident & CEOBuy22,950$0.54$12.4KForm 4
Dec 5, 2022Milford Scott RPresident & CEOBuy5,800$0.51$3.0KForm 4
Dec 1, 2022Bernstein BruceDirectorBuy33,890$0.43$14.6KForm 4
Nov 30, 2022Bernstein BruceDirectorBuy16,110$0.41$6.6KForm 4
Jun 17, 2022Ernst EzraPresident and CEOBuy12,602$0.79$10.0KForm 4
Apr 20, 2022WEINSTEIN ROBERTDirectorSale45,000$1.06$47.7KForm 4
Apr 18, 2022Milford Scott RPresident & CEOSale5,020$1.06$5.3KForm 4
Apr 14, 2022Milford Scott RPresident & CEOSale5,000$1.08$5.4KForm 4
Apr 13, 2022Milford Scott RPresident & CEOSale5,000$1.10$5.5KForm 4
Apr 12, 2022Milford Scott RPresident & CEOSale5,000$1.11$5.5KForm 4
Apr 11, 2022Milford Scott RPresident & CEOSale5,000$1.10$5.5KForm 4
Mar 17, 2022Bernstein BruceDirectorBuy5,000$1.23$6.2KForm 4
Mar 7, 2022Bernstein BruceDirectorSale15,000$1.00$15.0KForm 4
Jan 21, 2022Bernstein BruceDirectorSale25,000$1.46$36.5KForm 4
Jan 19, 2022WEINSTEIN ROBERTDirectorSale45,000$1.56$70.2KForm 4

All 24 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$35.0M 2025–2026
Money received by yearMoney received by year, 2025–2026: $35.0M in all. Private raises (Form D) $35.0M.$0$10M$20M$30M$40M2025 · Private raises (Form D): $4.0M20252026 · Private raises (Form D): $31.0M2026
Figures by year
YearPrivate raises (Form D)Total
2026$31.0M$31.0M
2025$4.0M$4.0M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Feb 27, 2026Raised $31 million in a private offering of equity57 Form D: 1 investor so far Form D
  2. Jan 14, 2025Raised $4 million in a private offering of equity85 Form D: 2 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Citadel Advisors LLC117,022$121.7K0.0%New
Wealthspire Advisors, LLC105,102$109.3K0.0%New
BlackRock, Inc.81,990$85.3K0.0%No change
Geode Capital Management, LLC56,069$58.3K0.0%−11,455
Vanguard Capital Management LLC51,310$53.4K0.0%No change
XTX Topco Ltd32,770$34.1K0.0%New
Jane Street Group, LLC31,216$32.5K0.0%−50,944
Vanguard Fiduciary Trust Co23,380$24.3K0.0%No change
Integrated Wealth Concepts LLC20,704$21.5K0.0%+10,352
State Street Corp16,144$16.8K0.0%No change
Citigroup Inc6,191$6.4K0.0%+3,615
Tower Research Capital LLC (TRC)5,754$6.0K0.0%+1,217
Morgan Stanley2,701$2.8K0.0%−19,186
Vanguard Global Advisers, LLC2,383$2.5K0.0%No change
Allworth Financial LP66$690.0%No change
Activest Wealth Management50$520.0%No change
SBI Securities Co., Ltd.15$160.0%No change
Caitong International Asset Management Co., Ltd8$80.0%+6
Steward Partners Investment Advisory, LLC3$30.0%New
Barclays PLC1$10.0%New
Royal Bank Of Canada1$00.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Vringo is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARXWELL, Inc.2
  • CIK0001410428
  • Employer ID (EIN)20-498812916
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company16
  • Incorporated inDelaware16
  • Fiscal year endsDecember 312
  • Industry code (SIC)7200 Services-Personal Services2
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance2
  • Business address254 West 31St Street, 11Th Floor, New York, NY 100012
  • Phone212 750-95952
  • Shares outstanding8,589,266 as of Aug 10, 202614
  • Public float$3.6M as of Jun 30, 202516
  • AuditorCBIZ CPAs P.C., Morristown, New Jersey PCAOB ID 199; no auditor attestation of internal control over financial reporting16
  • On EDGAR sinceAug 20, 20072
  • Filings1,054 in all: 4 (316), 8-K (280), 10-Q (49), 3 (43), CORRESP (32), UPLOAD (22), 425 (19), DEF 14A (18)2
    All 58 form types

    EFFECT (18), SC 13G (18), 10-K (16), DEFA14A (16), SC 13G/A (16), 4/A (14), 424B5 (14), 10-K/A (13), S-3 (13), 424B3 (11), PRE 14A (11), S-3/A (10), SC 13D/A (10), D (8), S-8 (7), 8-K/A (6), CT ORDER (6), SC 13D (6), 8-A12B (4), NT 10-K (4), NT 10-Q (4), S-1/A (4), S-4/A (4), 3/A (3), 424B2 (3), FWP (3), 25-NSE (2), 424B4 (2), D/A (2), POS AM (2), REGDEX (2), S-4 (2), SCHEDULE 13D (2), SCHEDULE 13G (2), SCHEDULE 13G/A (2), 10-Q/A (1), 25 (1), 305B2 (1), 5 (1), ARS (1), ARS/A (1), AW (1), CERTNAS (1), CERTNYS (1), NT 10-K/A (1), PREC14A (1), PREM14A (1), PRER14A (1), S-1 (1), SCHEDULE 13D/A (1)

  • Latest filingsAnnual report (10-K) Apr 1, 2026
    Quarterly report (10-Q) Aug 14, 2026
    Proxy statement (DEF 14A) Oct 8, 2026
    Latest 8-K (8-K) Oct 8, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, par value $0.01 per shareXWELNasdaq

From the cover page of the 10-K filed Apr 1, 2026 (Section 12(b) of the Exchange Act).16

Risk factors and legal proceedings

The risks Vringo names in Item 1A of its 10-K filed Apr 1, 2026: 60 risks under these headings, as written.16

  • Risks Related to our Financial Condition and Capital Requirements
  • Risks Related to our Business Operations
  • Risks Related to Capital Stock
  • Other Risk Factors
  • Our consolidated financial statements have been prepared on a going concern basis; we must raise additional capital to fund our operations in order to continue as a going concern.
  • Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.
  • Global economic and market conditions may adversely affect our business, financial condition, and operating results.
  • Increasing inflation could adversely affect our business, financial condition, results of operations or cash flows.
  • Our business requires substantial capital expenditures, and we may not have access to the capital required to maintain and grow our operations.
  • The bio surveillance monitoring activities conducted by XpresTest are funded partially by government contract awards, which may not be available to us in the future, and such contract awards are subject to guidelines regulating certain aspects of our operations.
  • Our ability to obtain funding for our bio surveillance monitoring activities from the CDC may be impacted by possible reductions in federal spending.
  • We operate globally and changes in tax laws could adversely affect our results.
The other 52 risks
  • If we fail to comply with the complex federal, state, local and foreign laws and regulations that apply to our businesses, we could suffer severe consequences that could materially and adversely affect our operating results and financial condition.
  • We have identified certain material weaknesses in our internal controls over financial reporting, which could impair our ability to produce accurate consolidated financial statements on a timely basis and result in material misstatements in our consolidated financial statements if not remediated. If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results and current and potential stockholders may lose confidence in our financial reporting
  • We cannot assure you that any of our remedial measures will be effective in resolving our material weaknesses.
  • We depend on third parties to provide services critical to our XpresTest bio surveillance business, and we depend on them to comply with applicable laws and regulations. Additionally, any breaches of the information technology systems of third parties could have a material adverse effect on our operations.
  • Our business operations and reputation may be materially impaired if we do not comply with privacy laws or information security policies.
  • Hardware and software failures or delays in our information technology systems, including failures resulting from our systems conversions or otherwise, could disrupt our operations and cause the loss of confidential information, customers and business opportunities or otherwise adversely impact our business.
  • We must comply with complex and overlapping laws protecting the privacy and security of personal data.
  • Our capital expenditures in Naples Wax locations may not generate a positive return and we will incur significant additional costs.
  • We rely on international and domestic airplane travel, and the time that airline passengers spend in United States airports post-security. A decrease in the desire of customers to buy spa services and products, or decreased time spent in airports would negatively impact our operations.
  • Our operations in United Arab Emirates can be negatively impacted by recent military conflict in the Middle East.
  • We rely on a limited number of distributors and suppliers for certain of our products, and events outside our control may disrupt our supply chain, which could result in an inability to perform our obligations under our concession agreements and cause us to lose our concessions.
  • Our operating results may fluctuate significantly due to certain factors, some of which are beyond our control.
  • Our expansion into new airports or off-airport locations may present increased risks due to unfamiliarity with those areas.
  • Our growth strategy is dependent in part on our ability to successfully identify and open new locations.
  • Our profitability relating to our operations depends on the number of airline passengers in the terminals in which we have concessions. Changes by airport authorities or airlines that lower the number of airline passengers in any of these terminals could affect our business, financial condition, and results of operations.
  • We may not be able to execute our growth strategy to expand and integrate new concessions, our recently acquired entity or future acquisitions into our business or remodel existing concessions. Any new concessions, future acquisitions or remodeling of existing concessions may divert management resources, result in unanticipated costs, or dilute the ownership of our stockholders.
  • If the estimates and assumptions we use to determine the size of our market are inaccurate, our future growth rate may be impacted.
  • We currently rely on a skilled, licensed labor force to provide our services, and the supply of this labor force is finite. If we cannot hire adequate staff for our locations, we will not be able to operate.
  • Our labor force could unionize, putting upward pressure on labor costs.
  • We compete for new locations in airports and may not be able to secure new locations.
  • We may not be able to predict accurately or fulfill customer preferences or demands.
  • Our leases may be terminated, either for convenience by the landlord or because of a XpresSpa or Naples Wax default.
  • Our ability to operate depends on the traffic patterns of the terminals in which we operate, and the cessation or disruption of air traveler traffic in these terminals would negatively impact XpresSpa’s and XpresTest’s addressable market.
  • We are dependent on our local partners.
  • Failure to comply with minimum airport concession disadvantaged business enterprise participation goals and requirements could lead to lost business opportunities or the loss of existing business.
  • Continued minimum wage increases could negatively impact our cost of labor.
  • Information technology systems failure or disruption, or changes to information technology related to payment systems, could impact our day-to-day operations.
  • If we are unable to protect our customers’ credit card data and other personal information, we could be exposed to data loss, litigation and liability, and our reputation could be significantly harmed.
  • Negative social media regarding XWELL, XpresSpa, XpresTest or Naples Wax Center could result in decreased revenues and impact our ability to recruit workers.
  • We employ people in multiple different jurisdictions, and the employment laws of those jurisdictions are subject to change. In addition, our services are regulated through government-issued operating licenses. Noncompliance with applicable laws could result in employee lawsuits or legal action taken by government authorities.
  • We source, develop, and sell products that may result in product liability defense costs and product liability payments.
  • We and our subsidiaries have been, are, and may again become involved in litigation that could divert management’s attention and harm our businesses.
  • New legislation, regulations or court rulings related to enforcing patents could harm our business and operating results.
  • Our failure or inability to protect the trademarks or other proprietary rights we use or claims of infringement by us of the rights of third parties, could adversely affect our competitive position or the value of our brands.
  • Any future acquisitions or business opportunities could involve unknown risks that could harm our business and adversely affect our financial condition and the results of operations.
  • Risks associated with international operations could result in additional costs and inefficiencies.
  • Risks Related to our Capital Stock
  • Stock prices can be volatile, and this volatility may depress the price of our common stock.
  • We have no current plans to pay dividends on our common stock, and our investors may not receive funds without selling their stock.
  • Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our common stock.
  • The Series H Certificate of Designations contains restrictive covenants and terms that may make it difficult to procure additional financing and that may affect our financial condition and results of operations.
  • In connection with February 2026 Private Placement, we are subject to certain restrictive covenants that may make it difficult to procure additional financing.
  • Substantial future sales or other issuances of our common stock could depress the market for our common stock.
  • You may experience future dilution as a result of future equity offerings and other issuances of our securities.
  • Future issuances of preferred stock may adversely affect the market price for our common stock.
  • Any additional capital raised through the sale of equity or equity-backed securities may dilute our stockholders’ ownership percentages and could also result in a decrease in the market value of our equity securities.
  • We may be unable to raise capital by offering shares of our common stock because we do not currently have enough authorized shares available for such a transaction.
  • Our common stock has historically traded in low volumes. We cannot predict whether an active trading market for our common stock will ever develop. Even if an active trading market develops, the market price of our common stock may be significantly volatile.
  • Anti-takeover provisions of Delaware law, provisions in our charter and bylaws, and our stockholder rights plan could prevent or frustrate attempts by stockholders to change our Board of Directors or current management and could delay, discourage, or make more difficult a third-party acquisition of control of us.
  • If securities analysts do not publish research or reports about our business, or if they publish negative evaluations, the price of our common stock could decline.
  • Having availed ourselves of scaled disclosure available to smaller reporting companies, we cannot be certain if such reduced disclosure will make our common stock less attractive to investors.
  • Our confidential information may be disclosed by other parties.
  • We may fail to meet publicly announced financial guidance or other expectations about our business, which would cause our stock to decline in value.

Legal proceedings

Litigation and legal proceedings

Certain of our outstanding legal matters include speculative claims for substantial or indeterminate amounts of damages. We regularly evaluate developments in our legal matters that could affect the amount of any potential liability and adjust as appropriate. Significant judgment is required to determine both the likelihood of there being any potential liability and the estimated amount of a loss related to our legal matters.

With respect to our outstanding legal matters, based on our current knowledge, our management believes that the amount or range of a potential loss will not, either individually or in the aggregate, have a material adverse effect on our business, consolidated financial position, results of operations or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. We evaluated the outstanding legal matters and assessed the probability and likelihood of the occurrence of liability. Based on management’s estimates, we did not record a liability for all outstanding legal matters as of December 31, 2025. Related legal fees are recorded in the period in which they are incurred.

November 2025 Employment Litigation

The opening of Item 3, Legal Proceedings.16

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85